Loading...
XNYS
CLVT
Market cap2.79bUSD
May 23, Last price  
4.08USD
1D
-2.63%
1Q
-15.70%
IPO
-57.50%
Name

Clarivate PLC

Chart & Performance

D1W1MN
XNYS:CLVT chart
No data to show
P/E
—
P/S
1.09
EPS
—
Div Yield, %
—
Shrs. gr., 5y
20.42%
Rev. gr., 5y
15.31%
Revenues
2.56b
-2.74%
917,634,000968,468,0001,254,047,0001,876,894,0002,659,800,0002,659,800,0002,628,800,0002,556,700,000
Net income
-668m
L-26.69%
-263,930,000-242,162,000-106,310,000-270,448,000-3,960,200,000-3,960,200,000-911,200,000-668,000,000
CFO
647m
-13.11%
6,667,000-26,100,000263,500,000323,767,000509,300,000509,300,000744,200,000646,600,000
Earnings
Aug 04, 2025

Profile

Clarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs. The company also provides Derwent products, which include Derwent Innovation, Techstreet, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; CompuMark products, such as trademark screening, searching, and watching products and services for businesses and law firms; and MarkMonitor products, which helps enterprises to establish, manage, optimize, and protect their online presence. It serves government and academic institutions, life science companies, and research and development corporations in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc is headquartered in London, the United Kingdom.
URL
https://clarivate.com/
IPO date
Oct 29, 2018
Employees
11,600
Domiciled in
GB
Incorporated in
JE

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑12
Income
Revenues
2,556,700
-2.74%
2,628,800
-1.17%
2,659,800
0.00%
Cost of revenue
869,200
906,400
954,000
Unusual Expense (Income)
NOPBT
1,687,500
1,722,400
1,705,800
NOPBT Margin
66.00%
65.52%
64.13%
Operating Taxes
82,900
(101,300)
(28,900)
Tax Rate
4.91%
NOPAT
1,604,600
1,823,700
1,734,700
Net income
(668,000)
-26.69%
(911,200)
-76.99%
(3,960,200)
0.00%
Dividends
(37,700)
(75,500)
(75,400)
Dividend yield
1.07%
1.21%
1.33%
Proceeds from repurchase of equity
(200,000)
(100,000)
(169,300)
BB yield
5.68%
1.61%
2.99%
Debt
Debt current
20,600
48,800
26,700
Long-term debt
4,645,700
4,847,500
5,176,500
Deferred revenue
38,700
38,500
Other long-term liabilities
72,500
41,900
140,100
Net debt
4,371,100
4,507,900
4,807,200
Cash flow
Cash from operating activities
646,600
744,200
509,300
CAPEX
(289,100)
(242,500)
(202,900)
Cash from investing activities
(236,700)
(237,400)
57,300
Cash from financing activities
(470,100)
(496,500)
(759,200)
FCF
1,683,600
1,781,400
1,734,700
Balance
Cash
295,200
370,700
348,800
Long term investments
17,700
47,200
Excess cash
167,365
256,960
263,010
Stockholders' equity
5,665,300
5,992,300
6,812,500
Invested Capital
9,636,635
10,649,040
11,832,690
ROIC
15.82%
16.22%
14.65%
ROCE
16.75%
15.44%
13.74%
EV
Common stock shares outstanding
693,600
671,600
678,600
Price
5.08
-45.14%
9.26
11.03%
8.34
-64.54%
Market cap
3,523,488
-43.34%
6,219,016
9.89%
5,659,524
-62.45%
EV
7,894,588
12,119,516
11,859,324
EBITDA
2,414,500
2,430,700
2,416,300
EV/EBITDA
3.27
4.99
4.91
Interest
283,400
293,700
270,300
Interest/NOPBT
16.79%
17.05%
15.85%